Docoh
Loading...

PHAS PhaseBio Pharmaceuticals

Institutional ownership

Data for period
(Last complete reporting period)
Institutional shares
Float
Outstanding shares
Total positions
Opened positions
Closed positions
Increased positions
Decreased positions

Latest institutional filings

Type Filer #Shares Filed For date #Previous %Chg Prev. Date
13F-HR/A
Altium Capital Management 775K 17 Nov 21 30 Sep 21 775K 0% 30 Jun 21
13F-HR/A
Johnson & Johnson 1.61M 16 Nov 21 30 Sep 21 1.61M 0% 31 Dec 19
13F-HR/A
BNP Paribas Arbitrage 380 16 Nov 21 30 Sep 21 301 +26% 30 Jun 21
13F-HR
Boothbay Fund Management 40.73K 15 Nov 21 30 Sep 21 40.56K 0% 30 Jun 21
13F-HR
Ergoteles 10.88K 15 Nov 21 30 Sep 21 69.8K -84% 30 Jun 21
13F-HR
Pura Vida Investments 27.94K 15 Nov 21 30 Sep 21 0 +∞% 30 Jun 21
13F-HR
Rock Springs Capital Management 1.84M 15 Nov 21 30 Sep 21 1.84M 0% 30 Jun 21
13F-HR
Marshall Wace 218.88K 15 Nov 21 30 Sep 21 0 +∞% 30 Jun 21
13F-HR
Ra Capital Management 2.85M 15 Nov 21 30 Sep 21 2.85M 0% 30 Jun 21
13F-HR
Citadel Advisors 2.73K 15 Nov 21 30 Sep 21 10.24K -73% 30 Jun 21

About this data

This data is updated daily from 13F, 13D and 13G SEC filings.

Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.

PHAS 5-year stock price

Institutional ownership trends

Institutional shares (*long positions only)
Number of holders
Opened vs closed positions (#holders, opened on top)
Increased vs decreased positions (#holders, increased on top)
Puts vs calls (#shares, puts on top)

Institutional ownership history data

All data in millions (MM) except percentages. "0.0" is < 100,000 and "0.0%" is < 0.1%
Filter holdings
Data to display
Shade data
Download data